Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:42:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Introduced a consolidated Locations section listing states and District of Columbia (California, District of Columbia, Florida, Georgia, Illinois, Maryland, Michigan, Missouri, New York, North Carolina, Ohio, Oregon, Tennessee, Texas, Washington, Wisconsin) and removed the separate per-state location pages.
    Difference
    1%
    Check dated 2025-12-23T17:29:34.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Editorial changes were made to the Publications section: a new note clarifies that PubMed-listed publications are automatically filled, and the page’s revision tag was updated to v3.3.2; a corresponding older note about PubMed-derived publications was removed and replaced (Revision: v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:37:55.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A government funding status notice banner was removed from the page, and this does not affect the study's details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T06:54:31.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No significant changes were detected on the Study Details page for NCT02152956; the title, URL, and primary content appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T20:56:50.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    2%
    Check dated 2025-10-06T05:19:11.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.